Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mannkind Corp. (MNKD)
NASDAQ:MNKD
Holding MNKD?
Track your performance easily
MNKD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.17 - $6.81
Previous Close$6.66
Volume1.85M
Average Volume (3M)2.73M
Market Cap
$1.83B
Enterprise Value$1.81B
Total Cash (Recent Filing)$247.76M
Total Debt (Recent Filing)$231.03M
Price to Earnings (P/E)184.5
Beta1.27
Next Earnings
Nov 05, 2024EPS Estimate
$0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.04
Shares Outstanding274,995,037
10 Day Avg. Volume2,325,286
30 Day Avg. Volume2,729,757
Standard Deviation0.18
R-Squared0.14
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)-8.12
Price to Sales (P/S)7.26
Price to Cash Flow (P/CF)117.70
P/FCF Ratio55.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue7.61
Enterprise Value/Gross Profit13.32
Enterprise Value/Ebitda55.52
Forecast
1Y Price Target
$8.33Price Target Upside25.08% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
MannKind News
PremiumPress Releases
MannKind to Present at Upcoming Conferences
PremiumCompany Announcements
MannKind Announces Board of Directors TransitionOwnership Overview
16.76% Insiders
11.30% Mutual Funds
26.97% Other Institutional Investors
44.96% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MNKD FAQ
What was Mannkind Corp.’s price range in the past 12 months?
Mannkind Corp. lowest stock price was $3.17 and its highest was $6.81 in the past 12 months.
What is Mannkind Corp.’s market cap?
Currently, no data Available
When is Mannkind Corp.’s upcoming earnings report date?
Mannkind Corp.’s upcoming earnings report date is Nov 05, 2024 which is in 47 days.
How were Mannkind Corp.’s earnings last quarter?
Mannkind Corp. released its earnings results on Aug 07, 2024. The company reported -$0.01 earnings per share for the quarter, missing the consensus estimate of $0.008 by -$0.018.
Is Mannkind Corp. overvalued?
According to Wall Street analysts Mannkind Corp.’s price is currently Undervalued.
Does Mannkind Corp. pay dividends?
Mannkind Corp. does not currently pay dividends.
What is Mannkind Corp.’s EPS estimate?
Mannkind Corp.’s EPS estimate is $0.03.
How many shares outstanding does Mannkind Corp. have?
Mannkind Corp. has 274,995,030 shares outstanding.
What happened to Mannkind Corp.’s price movement after its last earnings report?
Mannkind Corp. reported an EPS of -$0.01 in its last earnings report, missing expectations of $0.008. Following the earnings report the stock price went down -4.934%.
Which hedge fund is a major shareholder of Mannkind Corp.?
Among the largest hedge funds holding Mannkind Corp.’s share is Deerfield Management Company, LP. It holds Mannkind Corp.’s shares valued at 1M.
---
MannKind Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.33 (25.08% Upside)
$8.33 (25.08% Upside)
Blogger Sentiment
Bullish
MNKD Sentiment 85%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 28.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $837.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.7%
Last 30 Days ▲ 2.5%
Last 30 Days ▲ 2.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
53.45%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
41.61%
Trailing 12-Months
Company Description
Mannkind Corp.
MannKind Corp. is a biopharmaceutical company. It focuses on the discovery, development and, commercialization of therapeutic products for diseases, such as diabetes and cancer. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Westlake Village, CA.
---
MNKD Company Deck
---
MNKD Earnings Call
Q2 2024
0:00 / 0:00
---
MNKD Stock 12 Month Forecast
Average Price Target
$8.33
▲(25.08% Upside)
Technical Analysis
Best Analysts Covering MNKD
1 Year
1 Year Success Rate
12/29 ratings generated profit
1 Year Average Return
+26.31%
reiterated a buy rating 9 months ago
Copying Oren Livnat's trades and holding each position for 1 Year would result in 41.38% of your transactions generating a profit, with an average return of +26.31% per trade.
---